Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Respir Cell Mol Biol ; 50(2): 301-15, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24024586

ABSTRACT

Like many steroid receptors, the glucocorticoid (GC) receptor (GR) is a phosphoprotein. Although there are multiple phosphorylation sites critical for GR transcriptional activity (i.e., serine [S]203, S211, and S226), their respective role in driving GR functions is highly cell specific. We have recently identified protein phosphatase 5 as an essential Ser/Thr phosphatase responsible for impairing GR function via S211 dephosphorylation in airway smooth muscle (ASM) cells. Because p38 mitogen-activated protein kinase (MAPK) directly phosphorylates GR in different cell types in a stimulus- and cell-dependent manner, we investigated the role of p38 MAPK on GR phosphorylation and function in ASM cells. Cells were transfected with 100 nM p38 MAPK small interfering RNA or 2 µg MAPK kinase 3 expression vector (a specific kinase that directly activates p38 MAPK) in the presence or absence of fluticasone (100 nM) and/or p38 MAPK pharmacological inhibitor SB203580. We found that p38 MAPK blockade positively regulates GR nuclear translocation and GR-dependent induction of the steroid-target gene GC-induced leucine zipper in a hormone-independent manner. We also found that p38 MAPK-dependent regulation of GR functions was associated with a differential action on GR phosphorylation at S203 and S211 residues. This study demonstrated that the inactive state of GR in resting conditions is not only ensured by the absence of the GC ligand but also by p38 MAPK-dependent phosphorylation of unliganded GR at specific residues, which appears to be important in determining the overall GC responsiveness of ASM cells.


Subject(s)
Glucocorticoids/pharmacology , Myocytes, Smooth Muscle/metabolism , Receptors, Glucocorticoid/metabolism , Respiratory System/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Cells, Cultured , Humans , Imidazoles/pharmacology , Leucine Zippers/physiology , Myocytes, Smooth Muscle/drug effects , Phosphorylation/drug effects , Pyridines/pharmacology , Respiratory System/drug effects , Signal Transduction/physiology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
2.
Am J Respir Cell Mol Biol ; 47(4): 464-73, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22592921

ABSTRACT

Corticosteroid insensitivity (CSI) represents a profound challenge in managing patients with asthma. We recently demonstrated that short exposure of airway smooth muscle cells (ASMCs) to proasthmatic cytokines drastically reduced their responsiveness to glucocorticoids (GCs), an effect that was partially mediated via interferon regulatory factor-1, suggesting the involvement of additional mechanisms (Am J Respir Cell Mol Biol 2008;38:463-472). Although GC receptor (GR) can be phosphorylated at multiple serines in the N-terminal region, the major phosphorylation sites critical for GR transcriptional activity are serines 211 (Ser211) and 226 (Ser226). We tested the novel hypothesis that cytokine-induced CSI in ASMCs is due to an impaired GR phosphorylation. Cells were treated with TNF-α (10 ng/ml) and IFN-γ (500 UI/ml) for 6 hours and/or fluticasone (100 nm) added 2 hours before. GR was constitutively phosphorylated at Ser226 but not at Ser211 residues. Cytokines dramatically suppressed fluticasone-induced phosphorylation of GR on Ser211 but not on Ser226 residues while increasing the expression of Ser/Thr protein phosphatase (PP)5 but not that of PP1 or PP2A. Transfection studies using a reporter construct containing GC responsive elements showed that the specific small interfering RNA-induced mRNA knockdown of PP5, but not that of PP1 or PP2A, partially prevented the cytokine suppressive effects on GR-meditated transactivation activity. Similarly, cytokines failed to inhibit GC-induced GR-Ser211 phosphorylation when expression of PP5 was suppressed. We propose that the novel mechanism that proasthmatic cytokine-induced CSI in ASMCs is due, in part, to PP5-mediated impairment of GR-Ser211 phosphorylation.


Subject(s)
Cytokines/physiology , Myocytes, Smooth Muscle/enzymology , Nuclear Proteins/physiology , Phosphoprotein Phosphatases/physiology , Protein Processing, Post-Translational , Receptors, Glucocorticoid/metabolism , Respiratory System/cytology , Androstadienes/pharmacology , Cells, Cultured , Fluticasone , Gene Knockdown Techniques , Glucocorticoids/pharmacology , Glucocorticoids/physiology , Humans , Mutation, Missense , Myocytes, Smooth Muscle/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phosphoprotein Phosphatases/genetics , Phosphoprotein Phosphatases/metabolism , Phosphorylation , RNA Interference , Receptors, Glucocorticoid/genetics
3.
Vaccine ; 26(38): 4904-12, 2008 Sep 08.
Article in English | MEDLINE | ID: mdl-18680776

ABSTRACT

We investigated whether telomerase activity and viral gene transcription were associated with protection against the RB-1B strain of Marek's disease virus (MDV) in chickens vaccinated with Rispens CVI988 or the herpes virus of turkey (HVT). Telomerase activity in peripheral blood leukocytes (PBLs) seemed to be an appropriate marker of lymphoma and levels of viral transcription were correlated with the virulence of MDV strains. Vaccinated protected birds had lower levels of telomerase activity and RB-1B viral gene transcription than unvaccinated chickens infected with RB-1B. The decrease in RB-1B viral transcription was more marked in chickens vaccinated with CVI988 than in those vaccinated with HVT. Indeed, RB-1B viral transcription was not detectable after 14 days post-challenge. In conclusion, telomerase activity and gene transcription in challenge MDV strains are potential new reliable criteria of protection in vaccinated chickens.


Subject(s)
Chickens/immunology , Gene Expression Regulation , Leukocytes/virology , Mardivirus/genetics , Marek Disease Vaccines/immunology , Marek Disease/immunology , Marek Disease/virology , Telomerase/metabolism , Animals , Biomarkers, Tumor/metabolism , Chickens/genetics , Gene Expression Regulation, Viral , Genes, Viral/genetics , Herpesvirus 2, Gallid/genetics , Herpesvirus 2, Gallid/immunology , Leukocytes/enzymology , Leukocytes/immunology , Lymphoma/enzymology , Lymphoma/virology , Mardivirus/immunology , Marek Disease/enzymology , Marek Disease/prevention & control , Specific Pathogen-Free Organisms , Telomerase/genetics
4.
Arch Virol ; 153(8): 1563-8, 2008.
Article in English | MEDLINE | ID: mdl-18594940

ABSTRACT

The use of the complete DNA sequence for the Marek's disease virus (MDV) serotype 1 vaccine strain CVI988 Rispens in comparative genomic studies with virulent strains of MDV has revealed the presence of a number of insertions, deletions and single-nucleotide polymorphisms. In this study, we investigated a SNP in the H/ACA box of the viral RNA subunit of telomerase (vTR). We sequenced vTR from four different batches of CVI988 vaccine originating from a single commercial company. The A-to-G mutation defining the SNP in the H/ACA box of CVI988 vTR was present in only some of the batches. Thus, although this mutation affects CVI988 vTR function, it is not shared by all CVI988 isolates and may be a stochastic rather than causative event in CVI988 attenuation.


Subject(s)
Genetic Variation , Herpesvirus 2, Gallid/genetics , Marek Disease Vaccines/chemistry , RNA, Viral/chemistry , RNA/chemistry , Telomerase/chemistry , Animals , Herpesvirus 2, Gallid/immunology , Herpesvirus 2, Gallid/pathogenicity , Marek Disease/immunology , Marek Disease/prevention & control , Marek Disease Vaccines/genetics , Polymorphism, Single Nucleotide
SELECTION OF CITATIONS
SEARCH DETAIL
...